Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Net Cash Flow (2017 - 2025)

Historic Net Cash Flow for Inspire Medical Systems (INSP) over the last 9 years, with Q4 2025 value amounting to -$7.8 million.

  • Inspire Medical Systems' Net Cash Flow fell 37664.05% to -$7.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$45.0 million, marking a year-over-year decrease of 2766.74%. This contributed to the annual value of -$45.0 million for FY2025, which is 2766.74% down from last year.
  • Latest data reveals that Inspire Medical Systems reported Net Cash Flow of -$7.8 million as of Q4 2025, which was down 37664.05% from $5.8 million recorded in Q3 2025.
  • In the past 5 years, Inspire Medical Systems' Net Cash Flow ranged from a high of $231.4 million in Q3 2022 and a low of -$144.6 million during Q4 2023
  • Its 5-year average for Net Cash Flow is -$4.3 million, with a median of -$2.6 million in 2021.
  • As far as peak fluctuations go, Inspire Medical Systems' Net Cash Flow skyrocketed by 58748.14% in 2022, and later plummeted by 195524.34% in 2024.
  • Inspire Medical Systems' Net Cash Flow (Quarter) stood at $4.3 million in 2021, then skyrocketed by 451.98% to $23.6 million in 2022, then crashed by 712.38% to -$144.6 million in 2023, then skyrocketed by 101.94% to $2.8 million in 2024, then plummeted by 376.64% to -$7.8 million in 2025.
  • Its Net Cash Flow stands at -$7.8 million for Q4 2025, versus $5.8 million for Q3 2025 and $52.9 million for Q2 2025.